Here, we spiked whole blood with infliximab, a well characterized anti-tumor necrosis factor α (TNF-α) chimeric antibody used to treat autoimmune diseases including inflammatory bowel disease, arthritis, ankylosing spondylitis, and psoriasis. Here, TNF is linked to autoimmune disease.